Landmark Dusseldorf non-FRAND finding is big news for joint licensing programmes
SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling
SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling
Twenty-eight patent owners announced as charter participants in licensing platform launched last July
A spate of pharma-high tech innovation partnerships have dominated opening days of the year
John Chen expresses frustration at the time the transaction is taking to get over the line as IAM learns new details of its structure
23 September 2021
A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners
23 September 2021
The SSO's patent committee meets tomorrow but will continue accepting written comments until 15 October
20 September 2021
Saturday Opinion: IP and licensing failures are holding back adoption of superior technologies, argues Marconi’s Micky Minhas
18 September 2021
The acquisition of the rare disease specialist is latest development in the booming orphan drug deals market
14 September 2021
Japanese telecom provider inks a litigation-free deal with another major Chinese smartphone player
14 September 2021
09 September 2021
09 September 2021
09 September 2021
09 September 2021
Get unlimited access to all IAM content